They explained that the pathophysiology of type 2 diabetes is different in the elderly compared to that of younger age; as opposed to insulin resistance which mostly leads to diabetes at younger age, impaired insulin secretion is implicated in the elderly [42] which may affect the effectiveness of some medications such as metformin in the elderly [43]. This evidence concerns the gene INS and type 2 diabetes mellitus.